Contiguous Stage II Marginal Zone Lymphoma Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029471 (Contiguous Stage II Marginal Zone Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00891072Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryTreatment